![]() |
市場調查報告書
商品編碼
1801878
關節鏡器材市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Arthroscopy Instruments Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024年,全球關節鏡器材市場規模達65億美元,預計2034年將以3.9%的複合年成長率成長,達到94億美元。關節相關疾病發生率上升、老齡人口成長以及運動傷害增加是推動該市場發展的主要因素。目前,人們越來越傾向於微創手術,而關節鏡檢查因其恢復時間短、住院時間短、術後併發症少等優勢,成為首選方法。此外,視覺化技術、機器人整合以及對一次性器械的重視正在改變關節鏡檢查程序。患者對關節問題早期治療和診斷的認知不斷提高,也有助於刺激全球對這些器材的需求。
門診手術中心(尤其是在城市地區)正在迅速擴張,並成為門診關節鏡手術的主要中心,進一步推動了市場的成長。新興經濟體醫療基礎設施的不斷擴張,以及醫療支出的不斷成長,正在推動關節鏡技術和設備在公立和私人醫療機構的廣泛應用。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 65億美元 |
預測值 | 94億美元 |
複合年成長率 | 3.9% |
電動刮鬍刀系統在微創關節手術中發揮精準組織和骨骼切除的關鍵作用,在2024年佔據了23.9%的市場。其卓越的效率、便利的操作以及與先進視覺化系統無縫整合的能力,使其成為現代關節鏡手術的首選工具。電動刮鬍刀系統在門診手術中心的日益普及,有助於推動其普及,因為它們不僅縮短了手術時間,還提高了手術的精確度和成功率。
2024年,膝關節鏡手術佔了最大的市場佔有率,達到41.6%,這歸因於全球膝關節相關損傷和骨關節炎病例的激增。該領域受益於體育運動參與度的提高、老齡人口的增加以及微創干預的廣泛應用。韌帶撕裂和軟骨損傷通常使用關節鏡方法治療,使其成為最常用的手術方式。技術、工具和復健效果的改進繼續鞏固了其在已開發地區和發展中地區的主導地位。
2024年,北美關節鏡器材市場佔35.3%的市佔率。這一領先地位得益於其先進的外科基礎設施、尖端醫療技術的早期應用以及骨科手術的高頻率。美國和加拿大持續投資專科骨科中心和門診手術設施,從而實現了微創技術的大規模整合。預期壽命的延長,加上骨關節炎和運動傷害的發生率不斷上升,進一步加速了該地區對關節鏡器械的需求。
全球關節鏡器材市場的主要參與者包括奧林巴斯、Medacta、全錄輝、美敦力、Hemodia、史賽克、理查德·沃夫、CONMED、Karl Storz、Arthrex、Invamed、Zimmer Biomet、B. Braun 和 DePuy Synthes (J&J)。關節鏡器械市場的領先公司正在透過持續投資下一代手術技術來提升其地位。機器人技術、人工智慧驅動的可視化和一次性工具方面的創新正在幫助這些公司提供更高的精度、更短的恢復期和更好的臨床結果。一些參與者正在擴展其門診專用產品線,以滿足門診手術中心日益成長的需求。與醫療機構和運動醫學專家的策略合作使公司能夠開發適合不斷發展的手術技術的專用器材。此外,許多公司正透過加強區域分銷網路和推出具有成本效益的器械產品線來瞄準高成長的新興市場。
The Global Arthroscopy Instruments Market was valued at USD 6.5 billion in 2024 and is estimated to grow at a CAGR of 3.9% to reach USD 9.4 billion by 2034. Rising rates of joint-related conditions, a growing elderly population, and increasing sports injuries are among the major forces driving this market. There is a growing shift toward minimally invasive procedures, and arthroscopy stands out as a preferred approach due to its benefits, such as shorter recovery times, reduced hospital stays, and lower post-operative complications. Additionally, advancements in visualization technologies, robotics integration, and a greater emphasis on disposable devices are transforming arthroscopy procedures. Increasing patient awareness about early treatment and diagnosis of joint issues is also helping to fuel demand for these instruments globally.
Ambulatory surgical centers, especially in urban settings, are rapidly expanding and becoming major hubs for outpatient arthroscopy, contributing further to market growth. Expanding healthcare infrastructure in emerging economies, alongside rising expenditure, is encouraging broader adoption of arthroscopic techniques and devices across both public and private health sectors.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $6.5 Billion |
Forecast Value | $9.4 Billion |
CAGR | 3.9% |
The powered shaver systems captured a 23.9% share in 2024, owing to their essential role in delivering precise tissue and bone resection during minimally invasive joint procedures. Their superior efficiency, ease of handling, and ability to integrate seamlessly with advanced visualization systems make them a preferred tool in modern arthroscopic surgeries. Their growing use in outpatient surgical centers is helping fuel adoption, as they reduce operation time while enhancing precision and procedural success.
The knee arthroscopy segment held the largest market share at 41.6% in 2024, attributed to the high volume of knee-related injuries and osteoarthritis cases globally. The segment benefits from growing sports participation, a rise in elderly populations, and a broader shift toward minimally invasive interventions. Ligament tears and cartilage damage are routinely addressed using arthroscopic methods, making it the most performed procedure. Improvements in techniques, tools, and recovery outcomes continue to support its dominance across both developed and developing regions.
North America Arthroscopy Instruments Market held a 35.3% share in 2024. This leadership is driven by advanced surgical infrastructure, early adoption of cutting-edge medical technologies, and a high frequency of orthopedic procedures. The U.S. and Canada continue to invest in specialty orthopedic centers and outpatient surgical facilities, enabling wide-scale integration of minimally invasive techniques. Rising life expectancy, combined with the increasing prevalence of osteoarthritis and sports injuries, further accelerates the demand for arthroscopic tools across the region.
Key participants in the Global Arthroscopy Instruments Market include Olympus, Medacta, Smith & Nephew, Medtronic, Hemodia, Stryker, Richard Wolf, CONMED, Karl Storz, Arthrex, Invamed, Zimmer Biomet, B. Braun, and DePuy Synthes (J&J). Leading companies in the arthroscopy instruments market are advancing their position through consistent investment in next-generation surgical technologies. Innovations in robotics, AI-driven visualization, and disposable tools are helping these firms offer greater precision, shorter recovery periods, and enhanced clinical outcomes. Several players are expanding their outpatient-specific product lines to meet rising demand from ambulatory surgical centers. Strategic collaborations with healthcare institutions and sports medicine specialists are enabling companies to develop procedure-specific instruments tailored to evolving surgical techniques. Additionally, many are targeting high-growth emerging markets by strengthening regional distribution networks and launching cost-effective instrument lines.